Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 21

Trial Status

Completed2
Terminated1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Wenyin Shi, MD, PhD

Thomas Jefferson University

Moderately Similar
5 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma
Similarity Score30%

Evanthia Galanis

Mayo Clinic

Moderately Similar
2 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Jeffrey Weber

University of Southern California

Moderately Similar
4 trials

Shared therapeutic areas:

Stage IV MelanomaRecurrent Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

David Solit

Memorial Sloan Kettering Cancer Center

Moderately Similar
2 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Kevin Kim

M.D. Anderson Cancer Center

Moderately Similar
3 trials

Shared therapeutic areas:

Stage IV MelanomaRecurrent Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Paul Chapman

Memorial Sloan Kettering Cancer Center

Moderately Similar
3 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Robert Vonderheide, MD, DPhil

Abramson Cancer Center at Penn Medicine

Moderately Similar
3 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma
Similarity Score30%

Kim Margolin

SWOG Cancer Research Network

Moderately Similar
2 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Frank Hodi

Dana-Farber Cancer Institute

Moderately Similar
2 trials

Shared therapeutic areas:

Stage IV MelanomaRecurrent Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Thomas Gajewski

University of Chicago Comprehensive Cancer Center

Moderately Similar
3 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00438984Phase 1PrincipalInvestigator

Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma

Recurrent MelanomaStage IV Melanoma
Completed
NCT00553306Phase 1/2PrincipalInvestigator

Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma

Recurrent MelanomaStage IV Melanoma
Completed
NCT01106235Phase 1PrincipalInvestigator

Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma

Stage IV Melanoma
Terminated

All 3 trials loaded